PBYI logo

Puma Biotechnology (PBYI) Net Income

Annual Net Income

$21.59 M
+$21.59 M+1079450.00%

December 31, 2023


Summary


Performance

PBYI Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

Quarterly Net Income

$20.32 M
+$24.85 M+548.60%

September 30, 2024


Summary


Performance

PBYI Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

TTM Net Income

$23.24 M
+$14.52 M+166.53%

September 30, 2024


Summary


Performance

PBYI TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PBYI Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10000.0%+250.5%+525.3%
3 y3 years+136.0%+116.8%+167.4%
5 y5 years+119.0%+116.8%+167.4%

PBYI Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+174.1%at high+462.4%at high+147.5%
5 y5-yearat high+128.6%at high+145.5%at high+128.2%
alltimeall timeat high+107.4%at high+126.1%at high+107.7%

Puma Biotechnology Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
$20.32 M(-548.6%)
$23.24 M(+166.5%)
Jun 2024
-
-$4.53 M(-5.9%)
$8.72 M(-43.3%)
Mar 2024
-
-$4.82 M(-139.2%)
$15.38 M(-28.8%)
Dec 2023
$21.59 M(>+9900.0%)
$12.27 M(+111.7%)
$21.59 M(+480.9%)
Sep 2023
-
$5.80 M(+172.6%)
$3.72 M(-252.4%)
Jun 2023
-
$2.13 M(+51.7%)
-$2.44 M(-150.7%)
Mar 2023
-
$1.40 M(-125.0%)
$4.81 M(>+9900.0%)
Dec 2022
$2000.00(-100.0%)
-$5.61 M(+1457.2%)
$2000.00(-100.0%)
Sep 2022
-
-$360.00 K(-103.8%)
$9.83 M(-128.5%)
Jun 2022
-
$9.37 M(-375.4%)
-$34.48 M(-29.6%)
Mar 2022
-
-$3.40 M(-180.6%)
-$48.96 M(+68.7%)
Dec 2021
-$29.13 M(-51.5%)
$4.22 M(-109.5%)
-$29.03 M(-39.8%)
Sep 2021
-
-$44.67 M(+774.9%)
-$48.24 M(+37.7%)
Jun 2021
-
-$5.11 M(-130.9%)
-$35.03 M(+32.0%)
Mar 2021
-
$16.53 M(-210.2%)
-$26.53 M(-55.8%)
Dec 2020
-$59.99 M(-20.6%)
-$14.99 M(-52.3%)
-$59.99 M(+6.8%)
Sep 2020
-
-$31.46 M(-1026.7%)
-$56.20 M(+35.0%)
Jun 2020
-
$3.40 M(-120.0%)
-$41.62 M(-49.5%)
Mar 2020
-
-$16.93 M(+51.2%)
-$82.44 M(+9.1%)
Dec 2019
-$75.59 M(-33.4%)
-$11.20 M(-33.7%)
-$75.59 M(-20.5%)
Sep 2019
-
-$16.89 M(-54.9%)
-$95.09 M(+2.9%)
Jun 2019
-
-$37.42 M(+271.0%)
-$92.41 M(-7.0%)
Mar 2019
-
-$10.09 M(-67.1%)
-$99.32 M(-12.6%)
Dec 2018
-$113.58 M(-61.1%)
-$30.70 M(+116.1%)
-$113.58 M(-22.7%)
Sep 2018
-
-$14.20 M(-68.0%)
-$146.96 M(-30.0%)
Jun 2018
-
-$44.34 M(+82.1%)
-$209.94 M(-13.8%)
Mar 2018
-
-$24.34 M(-62.0%)
-$243.44 M(-16.6%)
Dec 2017
-$291.95 M(+5.8%)
-$64.08 M(-17.0%)
-$291.95 M(-2.9%)
Sep 2017
-
-$77.18 M(-0.8%)
-$300.54 M(+3.9%)
Jun 2017
-
-$77.83 M(+6.8%)
-$289.14 M(+4.0%)
Mar 2017
-
-$72.86 M(+0.3%)
-$277.90 M(+0.7%)
Dec 2016
-$276.01 M
-$72.66 M(+10.5%)
-$276.01 M(+4.1%)
Sep 2016
-
-$65.78 M(-1.2%)
-$265.07 M(+2.1%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$66.60 M(-6.2%)
-$259.70 M(+0.7%)
Mar 2016
-
-$70.97 M(+15.0%)
-$257.80 M(+7.7%)
Dec 2015
-$239.28 M(+68.6%)
-$61.72 M(+2.2%)
-$239.28 M(+6.3%)
Sep 2015
-
-$60.42 M(-6.6%)
-$225.05 M(+12.3%)
Jun 2015
-
-$64.69 M(+23.3%)
-$200.47 M(+14.8%)
Mar 2015
-
-$52.45 M(+10.5%)
-$174.63 M(+23.0%)
Dec 2014
-$141.97 M(+159.7%)
-$47.48 M(+32.5%)
-$141.97 M(+28.6%)
Sep 2014
-
-$35.84 M(-7.7%)
-$110.43 M(+24.3%)
Jun 2014
-
-$38.84 M(+96.2%)
-$88.87 M(+41.8%)
Mar 2014
-
-$19.79 M(+24.1%)
-$62.67 M(+14.7%)
Dec 2013
-$54.66 M(-26.5%)
-$15.95 M(+11.6%)
-$54.66 M(-9.8%)
Sep 2013
-
-$14.28 M(+12.9%)
-$60.63 M(-16.0%)
Jun 2013
-
-$12.65 M(+7.4%)
-$72.20 M(-2.8%)
Mar 2013
-
-$11.78 M(-46.2%)
-$74.31 M(-0.1%)
Dec 2012
-$74.35 M(+626.6%)
-$21.91 M(-15.3%)
-$74.35 M(+19.4%)
Sep 2012
-
-$25.86 M(+75.3%)
-$62.29 M(+69.4%)
Jun 2012
-
-$14.75 M(+24.8%)
-$36.77 M(+66.7%)
Mar 2012
-
-$11.83 M(+20.1%)
-$22.06 M(+115.5%)
Dec 2011
-$10.23 M(>+9900.0%)
-$9.85 M(+2734.6%)
-$10.23 M(+2576.7%)
Sep 2011
-
-$347.40 K(+912.8%)
-$382.30 K(+903.4%)
Jun 2011
-
-$34.30 K(+779.5%)
-$38.10 K(+514.5%)
Mar 2011
-
-$3900.00(-218.2%)
-$6200.00(-11.4%)
Dec 2010
-$7000.00(-58.3%)
$3300.00(-203.1%)
-$7000.00(-48.5%)
Sep 2010
-
-$3200.00(+33.3%)
-$13.60 K(-0.7%)
Jun 2010
-
-$2400.00(-48.9%)
-$13.70 K(-11.6%)
Mar 2010
-
-$4700.00(+42.4%)
-$15.50 K(-7.7%)
Dec 2009
-$16.80 K(+19.1%)
-$3300.00(0.0%)
-$16.80 K(+7.0%)
Sep 2009
-
-$3300.00(-21.4%)
-$15.70 K(-4.3%)
Jun 2009
-
-$4200.00(-30.0%)
-$16.40 K(+5.1%)
Mar 2009
-
-$6000.00(+172.7%)
-$15.60 K(+10.6%)
Dec 2008
-$14.10 K
-$2200.00(-45.0%)
-$14.10 K(+18.5%)
Sep 2008
-
-$4000.00(+17.6%)
-$11.90 K(+50.6%)
Jun 2008
-
-$3400.00(-24.4%)
-$7900.00(+75.6%)
Mar 2008
-
-$4500.00
-$4500.00

FAQ

  • What is Puma Biotechnology annual net profit?
  • What is the all time high annual net income for Puma Biotechnology?
  • What is Puma Biotechnology annual net income year-on-year change?
  • What is Puma Biotechnology quarterly net profit?
  • What is the all time high quarterly net income for Puma Biotechnology?
  • What is Puma Biotechnology quarterly net income year-on-year change?
  • What is Puma Biotechnology TTM net profit?
  • What is the all time high TTM net income for Puma Biotechnology?
  • What is Puma Biotechnology TTM net income year-on-year change?

What is Puma Biotechnology annual net profit?

The current annual net income of PBYI is $21.59 M

What is the all time high annual net income for Puma Biotechnology?

Puma Biotechnology all-time high annual net profit is $21.59 M

What is Puma Biotechnology annual net income year-on-year change?

Over the past year, PBYI annual net profit has changed by +$21.59 M (+1079450.00%)

What is Puma Biotechnology quarterly net profit?

The current quarterly net income of PBYI is $20.32 M

What is the all time high quarterly net income for Puma Biotechnology?

Puma Biotechnology all-time high quarterly net profit is $20.32 M

What is Puma Biotechnology quarterly net income year-on-year change?

Over the past year, PBYI quarterly net profit has changed by +$14.52 M (+250.53%)

What is Puma Biotechnology TTM net profit?

The current TTM net income of PBYI is $23.24 M

What is the all time high TTM net income for Puma Biotechnology?

Puma Biotechnology all-time high TTM net profit is $23.24 M

What is Puma Biotechnology TTM net income year-on-year change?

Over the past year, PBYI TTM net profit has changed by +$19.52 M (+525.26%)